tiprankstipranks
Trending News
More News >
Vir Biotechnology, Inc. (VIR)
:VIR
US Market

Vir Biotechnology (VIR) Stock Investors

Compare
1,347 Followers
Based on 797,653 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold VIR
On average, investors allocate 2.80% of their portfolios to VIR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 797,653 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VIR

1.4%
Last 7
Days
6.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VIR, out of 797,653 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VIR Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
2.29%
$9.91
Increased
1.50%
$7.44
Based on the activity of investors who made their portfolios public
The table shows changes in VIR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VIR Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Lucid Group
5.35%
-0.12%
+2.39%
7.65B
Consumer Cyclical
Nio
8.67%
-0.50%
-1.55%
8.42B
Consumer Cyclical
Block
3.64%
-0.60%
+1.19%
36.00B
Technology
JD
4.71%
-0.59%
-1.41%
60.08B
Consumer Cyclical
Riot Platforms
4.52%
-0.94%
-1.37%
2.54B
Financial
Delta Air Lines
4.51%
-0.66%
+0.65%
26.69B
Industrials
Zscaler
3.59%
-0.21%
-0.29%
34.99B
Technology
Marathon Digital Holdings
4.98%
-1.12%
-1.21%
4.62B
Financial
Abbott Laboratories
3.43%
-1.69%
-0.07%
220.05B
Healthcare
Viking Therapeutics
3.82%
-0.79%
-0.72%
3.24B
Healthcare
Based on the activity of 797,653 active portfolios
Open your Smart Portfolio

VIR Investor Analysis

VIR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.9%
of VIR holders
are under 35
Average Segment Performance
Average P/E Ratio16.12
Beta5.03
Dividend Yield4.20%
VIR investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
49.2%
of VIR holders
are between 35–55
Average Segment Performance
Average P/E Ratio14.67
Beta13.16
Dividend Yield3.60%
VIR investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
42.9%
of VIR holders
are over 55
Average Segment Performance
Average P/E Ratio10.19
Beta7.22
Dividend Yield3.90%
Overview of age group and performance of VIR stock investors
See who invests in VIR according to age group and performance.

FAQ

How many retail Investors hold VIR?
<0.1% of TipRanks' retail investors hold VIR in their portfolios.
    What is VIR Investor Sentiment?
    VIR’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of VIR in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of VIR in the last 7 days.
        What percentage of retail investors changed their holding of VIR in the last 30 days?
        ▼ 6.1% of TipRanks' retail investors changed their holding of VIR in the last 30 days.
          What is the average age of retail investors who hold VIR?
          The average age of VIR Holders is between 35–55.
            What other stocks have VIR investors also bought?
            VIR Investors also bought LCID, NIO, XYZ, JD, RIOT, DAL, ZS, MARA, ABT, VKTX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              CORCencora
              ANGOAngioDynamics
              BSXBoston Scientific
              CAHCardinal Health
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis